DCOY
NASDAQ · Biotechnology
Decoy Therapeutics Inc
$0.78
+0.16 (+25.79%)
Open$0.64
Previous Close$0.62
Day High$0.78
Day Low$0.63
52W High$43.86
52W Low$22.27
Volume—
Avg Volume778.0K
Market Cap4.98M
P/E Ratio36.07
EPS$1.11
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+5,609.7% upside
Current
$0.78
$0.78
Target
$44.53
$44.53
$37.12
$44.53 avg
$63.68
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.28M | 1.20M | 1.36M |
| Net Income | 141.5K | 105.1K | 144.5K |
| Profit Margin | 11.1% | 8.8% | 10.6% |
| EBITDA | 291.4K | 241.4K | 275.9K |
| Free Cash Flow | 83.4K | 101.2K | 72.7K |
| Rev Growth | +11.3% | +13.4% | -9.5% |
| Debt/Equity | 0.31 | 0.28 | 0.30 |
Dividend
Dividend Yield2.89%
Annual Dividend$1.15
Payout Ratio95.0%
Frequencyquarterly
Ex-DividendMar 5, 2026
Pay DateMar 26, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |